Logo image of DRW8.DE

DRAEGERWERK AG (DRW8.DE) Stock Fundamental Analysis

Europe - Frankfurt Stock Exchange - FRA:DRW8 - DE0005550602 - Common Stock

60.4 EUR
+0.4 (+0.67%)
Last: 1/15/2026, 12:36:58 PM
Fundamental Rating

5

Overall DRW8 gets a fundamental rating of 5 out of 10. We evaluated DRW8 against 68 industry peers in the Health Care Equipment & Supplies industry. DRW8 has only an average score on both its financial health and profitability. DRW8 is valued quite cheap, while showing a decent growth score. This is a good combination! DRW8 also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

4

1. Profitability

1.1 Basic Checks

  • In the past year DRW8 was profitable.
  • In the past year DRW8 had a positive cash flow from operations.
  • Of the past 5 years DRW8 4 years were profitable.
  • DRW8 had a positive operating cash flow in 4 of the past 5 years.
DRW8.DE Yearly Net Income VS EBIT VS OCF VS FCFDRW8.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M 400M

1.2 Ratios

  • DRW8 has a Return On Assets (3.99%) which is comparable to the rest of the industry.
  • DRW8's Return On Equity of 8.02% is in line compared to the rest of the industry. DRW8 outperforms 55.88% of its industry peers.
  • Looking at the Return On Invested Capital, with a value of 7.67%, DRW8 is in the better half of the industry, outperforming 63.24% of the companies in the same industry.
Industry RankSector Rank
ROA 3.99%
ROE 8.02%
ROIC 7.67%
ROA(3y)1.84%
ROA(5y)3.09%
ROE(3y)3.69%
ROE(5y)7.99%
ROIC(3y)N/A
ROIC(5y)N/A
DRW8.DE Yearly ROA, ROE, ROICDRW8.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5 10 15

1.3 Margins

  • Looking at the Profit Margin, with a value of 3.54%, DRW8 is in line with its industry, outperforming 44.12% of the companies in the same industry.
  • DRW8's Profit Margin has improved in the last couple of years.
  • DRW8's Operating Margin of 6.02% is on the low side compared to the rest of the industry. DRW8 is outperformed by 61.76% of its industry peers.
  • In the last couple of years the Operating Margin of DRW8 has grown nicely.
  • With a Gross Margin value of 45.35%, DRW8 is not doing good in the industry: 67.65% of the companies in the same industry are doing better.
  • DRW8's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 6.02%
PM (TTM) 3.54%
GM 45.35%
OM growth 3Y-13.99%
OM growth 5Y11.88%
PM growth 3Y-2.93%
PM growth 5Y32.71%
GM growth 3Y-1.06%
GM growth 5Y0.96%
DRW8.DE Yearly Profit, Operating, Gross MarginsDRW8.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20 30 40

5

2. Health

2.1 Basic Checks

  • With a Return on Invested Capital (ROIC) just above the Cost of Capital (WACC), DRW8 is creating some value.
  • The number of shares outstanding for DRW8 has been reduced compared to 1 year ago.
  • Compared to 5 years ago, DRW8 has more shares outstanding
  • The debt/assets ratio for DRW8 has been reduced compared to a year ago.
DRW8.DE Yearly Shares OutstandingDRW8.DE Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 5M 10M 15M
DRW8.DE Yearly Total Debt VS Total AssetsDRW8.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

  • An Altman-Z score of 2.66 indicates that DRW8 is not a great score, but indicates only limited risk for bankruptcy at the moment.
  • DRW8 has a Altman-Z score of 2.66. This is comparable to the rest of the industry: DRW8 outperforms 55.88% of its industry peers.
  • The Debt to FCF ratio of DRW8 is 2.16, which is a good value as it means it would take DRW8, 2.16 years of fcf income to pay off all of its debts.
  • DRW8 has a better Debt to FCF ratio (2.16) than 76.47% of its industry peers.
  • A Debt/Equity ratio of 0.10 indicates that DRW8 is not too dependend on debt financing.
  • DRW8 has a better Debt to Equity ratio (0.10) than 76.47% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 2.16
Altman-Z 2.66
ROIC/WACC1.2
WACC6.37%
DRW8.DE Yearly LT Debt VS Equity VS FCFDRW8.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

  • A Current Ratio of 1.76 indicates that DRW8 should not have too much problems paying its short term obligations.
  • DRW8 has a Current ratio (1.76) which is in line with its industry peers.
  • A Quick Ratio of 1.03 indicates that DRW8 should not have too much problems paying its short term obligations.
  • DRW8's Quick ratio of 1.03 is in line compared to the rest of the industry. DRW8 outperforms 44.12% of its industry peers.
Industry RankSector Rank
Current Ratio 1.76
Quick Ratio 1.03
DRW8.DE Yearly Current Assets VS Current LiabilitesDRW8.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

4

3. Growth

3.1 Past

  • DRW8 shows a small growth in Earnings Per Share. In the last year, the EPS has grown by 6.68%.
  • DRW8 shows a strong growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 36.42% yearly.
  • DRW8 shows a small growth in Revenue. In the last year, the Revenue has grown by 2.14%.
  • DRW8 shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.92% yearly.
EPS 1Y (TTM)6.68%
EPS 3Y-2.51%
EPS 5Y36.42%
EPS Q2Q%143.82%
Revenue 1Y (TTM)2.14%
Revenue growth 3Y0.42%
Revenue growth 5Y3.92%
Sales Q2Q%7.58%

3.2 Future

  • DRW8 is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 7.93% yearly.
  • Based on estimates for the next years, DRW8 will show a small growth in Revenue. The Revenue will grow by 2.85% on average per year.
EPS Next Y5.38%
EPS Next 2Y11.08%
EPS Next 3Y11.69%
EPS Next 5Y7.93%
Revenue Next Year2.84%
Revenue Next 2Y3.51%
Revenue Next 3Y3.67%
Revenue Next 5Y2.85%

3.3 Evolution

  • When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
  • The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
DRW8.DE Yearly Revenue VS EstimatesDRW8.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2017 2019 2021 2023 2025 2027 2029 2031 2033 1B 2B 3B 4B
DRW8.DE Yearly EPS VS EstimatesDRW8.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 0 5 10

7

4. Valuation

4.1 Price/Earnings Ratio

  • A Price/Earnings ratio of 9.36 indicates a reasonable valuation of DRW8.
  • Based on the Price/Earnings ratio, DRW8 is valued cheaper than 98.53% of the companies in the same industry.
  • DRW8 is valuated cheaply when we compare the Price/Earnings ratio to 27.33, which is the current average of the S&P500 Index.
  • DRW8 is valuated reasonably with a Price/Forward Earnings ratio of 8.23.
  • Based on the Price/Forward Earnings ratio, DRW8 is valued cheaply inside the industry as 94.12% of the companies are valued more expensively.
  • When comparing the Price/Forward Earnings ratio of DRW8 to the average of the S&P500 Index (24.12), we can say DRW8 is valued rather cheaply.
Industry RankSector Rank
PE 9.36
Fwd PE 8.23
DRW8.DE Price Earnings VS Forward Price EarningsDRW8.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

  • Based on the Enterprise Value to EBITDA ratio, DRW8 is valued cheaper than 98.53% of the companies in the same industry.
  • Based on the Price/Free Cash Flow ratio, DRW8 is valued cheaply inside the industry as 97.06% of the companies are valued more expensively.
Industry RankSector Rank
P/FCF 8.28
EV/EBITDA 3.28
DRW8.DE Per share dataDRW8.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 50 100 150

4.3 Compensation for Growth

  • DRW8's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
PEG (NY)1.74
PEG (5Y)0.26
EPS Next 2Y11.08%
EPS Next 3Y11.69%

7

5. Dividend

5.1 Amount

  • DRW8 has a Yearly Dividend Yield of 3.28%. Purely for dividend investing, there may be better candidates out there.
  • Compared to an average industry Dividend Yield of 1.13, DRW8 pays a better dividend. On top of this DRW8 pays more dividend than 92.65% of the companies listed in the same industry.
  • Compared to an average S&P500 Dividend Yield of 1.91, DRW8 pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.28%

5.2 History

  • On average, the dividend of DRW8 grows each year by 51.02%, which is quite nice.
Dividend Growth(5Y)51.02%
Div Incr Years2
Div Non Decr Years4
DRW8.DE Yearly Dividends per shareDRW8.DE Yearly Dividends per shareYearly Dividends per share 2019 2020 2021 2022 2023 2024 2025 0.5 1 1.5

5.3 Sustainability

  • 31.13% of the earnings are spent on dividend by DRW8. This is a low number and sustainable payout ratio.
  • DRW8's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP31.13%
EPS Next 2Y11.08%
EPS Next 3Y11.69%
DRW8.DE Yearly Income VS Free CF VS DividendDRW8.DE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M -100M 200M -200M 300M
DRW8.DE Dividend Payout.DRW8.DE Dividend Payout, showing the Payout Ratio.DRW8.DE Dividend Payout.PayoutRetained Earnings

DRAEGERWERK AG

FRA:DRW8 (1/15/2026, 12:36:58 PM)

60.4

+0.4 (+0.67%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)10-29
Earnings (Next)03-24
Inst Owners10.08%
Inst Owner ChangeN/A
Ins OwnersN/A
Ins Owner ChangeN/A
Market Cap1.13B
Revenue(TTM)3.42B
Net Income(TTM)120.88M
Analysts81.33
Price Target82.49 (36.57%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.28%
Yearly Dividend1.77
Dividend Growth(5Y)51.02%
DP31.13%
Div Incr Years2
Div Non Decr Years4
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)11.47%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.26%
EPS NY rev (3m)2.65%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)-0.06%
Revenue NY rev (3m)0.08%
Valuation
Industry RankSector Rank
PE 9.36
Fwd PE 8.23
P/S 0.33
P/FCF 8.28
P/OCF 5.58
P/B 0.75
P/tB 0.97
EV/EBITDA 3.28
EPS(TTM)6.45
EY10.68%
EPS(NY)7.34
Fwd EY12.15%
FCF(TTM)7.29
FCFY12.08%
OCF(TTM)10.82
OCFY17.91%
SpS182.27
BVpS80.37
TBVpS62.21
PEG (NY)1.74
PEG (5Y)0.26
Graham Number108
Profitability
Industry RankSector Rank
ROA 3.99%
ROE 8.02%
ROCE 10.2%
ROIC 7.67%
ROICexc 8.64%
ROICexgc 10.67%
OM 6.02%
PM (TTM) 3.54%
GM 45.35%
FCFM 4%
ROA(3y)1.84%
ROA(5y)3.09%
ROE(3y)3.69%
ROE(5y)7.99%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3Y-18.01%
ROICexgc growth 5Y12.44%
ROICexc growth 3Y-16.98%
ROICexc growth 5Y13.06%
OM growth 3Y-13.99%
OM growth 5Y11.88%
PM growth 3Y-2.93%
PM growth 5Y32.71%
GM growth 3Y-1.06%
GM growth 5Y0.96%
F-Score7
Asset Turnover1.13
Health
Industry RankSector Rank
Debt/Equity 0.1
Debt/FCF 2.16
Debt/EBITDA 0.44
Cap/Depr 44.92%
Cap/Sales 1.93%
Interest Coverage 11.48
Cash Conversion 57.51%
Profit Quality 113.22%
Current Ratio 1.76
Quick Ratio 1.03
Altman-Z 2.66
F-Score7
WACC6.37%
ROIC/WACC1.2
Cap/Depr(3y)46.64%
Cap/Depr(5y)59.31%
Cap/Sales(3y)2.11%
Cap/Sales(5y)2.52%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)6.68%
EPS 3Y-2.51%
EPS 5Y36.42%
EPS Q2Q%143.82%
EPS Next Y5.38%
EPS Next 2Y11.08%
EPS Next 3Y11.69%
EPS Next 5Y7.93%
Revenue 1Y (TTM)2.14%
Revenue growth 3Y0.42%
Revenue growth 5Y3.92%
Sales Q2Q%7.58%
Revenue Next Year2.84%
Revenue Next 2Y3.51%
Revenue Next 3Y3.67%
Revenue Next 5Y2.85%
EBIT growth 1Y12.74%
EBIT growth 3Y-13.63%
EBIT growth 5Y16.27%
EBIT Next Year83.49%
EBIT Next 3Y27.99%
EBIT Next 5Y13.13%
FCF growth 1Y20.52%
FCF growth 3Y-27.65%
FCF growth 5Y0.28%
OCF growth 1Y11.8%
OCF growth 3Y-24.25%
OCF growth 5Y0.35%

DRAEGERWERK AG / DRW8.DE FAQ

Can you provide the ChartMill fundamental rating for DRAEGERWERK AG?

ChartMill assigns a fundamental rating of 5 / 10 to DRW8.DE.


What is the valuation status of DRAEGERWERK AG (DRW8.DE) stock?

ChartMill assigns a valuation rating of 7 / 10 to DRAEGERWERK AG (DRW8.DE). This can be considered as Undervalued.


What is the profitability of DRW8 stock?

DRAEGERWERK AG (DRW8.DE) has a profitability rating of 4 / 10.


Can you provide the PE and PB ratios for DRW8 stock?

The Price/Earnings (PE) ratio for DRAEGERWERK AG (DRW8.DE) is 9.36 and the Price/Book (PB) ratio is 0.75.


What is the expected EPS growth for DRAEGERWERK AG (DRW8.DE) stock?

The Earnings per Share (EPS) of DRAEGERWERK AG (DRW8.DE) is expected to grow by 5.38% in the next year.